Clinical Trial Update: Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC [NA]

View source ↗

Summary

A first-line trial of irinotecan-loaded DC Bead chemoembolisation with cetuximab and 5-FU/leucovorin for KRAS wild-type metastatic colorectal cancer has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Irinotecan-loaded DC Bead (irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Liver Metastases, Colorectal Cancer | NA | Status: WITHDRAWN